Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01944098 · ClinicalTrials.gov registry record · Phase 3

Intraoperative Lidocaine Infusion for Postoperative Pain Management in Obese Patients

A Phase 3 study, sponsored by University of South Florida.

Completed
Registry status
Phase 3
Development phase
20
Enrollment target

NCT01944098: Completed Phase 3 study, sponsored by University of South Florida.

NCT01944098 is a Phase 3 study that has completed, run by University of South Florida. The registered enrollment target is 20 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01944098, a Phase 3 study, has completed, sponsored by University of South Florida.

COMPLETED
Registry status
Phase 3
Development phase
20 participants
Enrollment target

Study Summary

The primary objective is to assess the feasibility and safety of administering continuous intraoperative lidocaine infusions in adult patients undergoing laparoscopic Roux en Y Gastric Bypass (RYGB). The secondary objective is to determine if lidocaine administration versus placebo (dextrose administration) (initiated at the time of anesthesia induction and continued until extubation) will reduce postoperative narcotic requirements.

Primary Outcome

Analysis of patient outcome will involve a series of visual analogue scale pain evaluations during mobilization, coughing, and resting. VAS, 0 cm as no pain - 10 cm as maximum pain

Interventions

  • DRUG Placebo
  • DRUG Lidocaine

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2013-08
Est. Completion 2014-09
Phase Phase 3
University of South Florida

252 total trials

What the finished NCT01944098 record still lists

NCT01944098 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT01944098 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01944098 about?

NCT01944098 is a clinical study titled "Intraoperative Lidocaine Infusion for Postoperative Pain Management in Obese Patients". The primary objective is to assess the feasibility and safety of administering continuous intraoperative lidocaine infusions in adult patients undergoing laparoscopic Roux en Y Gastric Bypass (RYGB). The secondary objective is to determine if lidocaine administration versus placebo (dextrose adminis...

What is the current status of trial NCT01944098?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2013-08. Estimated completion is 2014-09.

What interventions are being tested in trial NCT01944098?

The interventions under investigation include: Placebo (DRUG), Lidocaine (DRUG).

Who is sponsoring clinical trial NCT01944098?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01944098's enrollment target sits among peer trials

20 1956th of 2000 higher than 32 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01944098, the US trial registry maintained by the National Library of Medicine. NCT01944098 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.